3M Sheds Its Drug-Delivery Business

3M Sheds Its Drug-Delivery Business

Source: 
Medical Devices and Diagnostics Industry
snippet: 

The company plans to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for $650 million plus a 17% noncontrolling interest in the new company. 3M also will keep transdermal drug delivery components business.